Ousia Pharma

Ousia Pharma

Forskning inden for bioteknologi

Danish biotech company developing peptide-small molecule drugs for treatment of obesity

Om os

Ousia Pharma is a biotech spin-out from the University of Copenhagen developing novel peptide-drug conjugates for treatment of obesity and metabolic diseases. The company uses a proprietary targeting approach in which peptides are used to deliver modulators of synaptic plasticity to drive a potent and sustained weight loss without compromising safety. A main objective of Ousia Pharma is to advance the development of the lead weight loss drug candidate (OP-56) within general obesity.

Branche
Forskning inden for bioteknologi
Virksomhedsstørrelse
2-10 medarbejdere
Hovedkvarter
Copenhagen
Type
Privat

Beliggenheder

Medarbejdere hos Ousia Pharma

Opdateringer

Tilsvarende sider